Information for people living with aspergillosis (ABPA, CPA and related conditions)
What the evidence says right now
Signals pointing to a tougher flu season
-
Southern Hemisphere “preview.” Australia saw higher-than-usual flu notifications in early 2025 compared with 2024, which often foreshadows a busier winter in the UK and Europe. That doesn’t guarantee the same for us, but it’s a warning sign. ausvaxsafety.org.au
- By September 2025 the numbers of cases in Australia had reached similar levels to those seen in 2024 www.health.gov.au
-
Co-circulation of viruses. In recent winters, influenza, RSV and COVID-19 have circulated together, increasing pressure on people at risk and on health services. WHO continues to flag this pattern in seasonal updates. World Health Organization
-
UK picture (late Sept 2025). UKHSA reports flu and COVID-19 at baseline/low levels for now. Activity can rise quickly as weather cools and schools/universities return. GOV.UK
-
Vaccine effectiveness (VE). Last season’s European interim VE against influenza A was ~32–53%, which is moderate—helpful at preventing severe illness and hospitalisation, especially in higher-risk groups. Effectiveness varies by age, strain and match. PMC
-
Timing. After Southern Hemisphere signals and based on past seasons, an earlier start (late Oct–Nov) with a Dec–Jan peak is plausible, though not certain. Local surveillance will confirm if that pattern emerges.
Why forecasts are uncertain (and what can improve outcomes)
-
Vaccine uptake. Higher uptake = smaller peaks and fewer hospitalisations. GOV.UK
-
Strain match. If circulating strains stay close to vaccine strains, protection is better; drift reduces it. PMC
-
Public behaviour. Ventilation, masks in crowded indoor spaces, and staying home when unwell still reduce spread. NHS Covid
-
Population immunity & health-system readiness. Recent infections and prior vaccines help; NHS readiness also matters.
What this means if you have aspergillosis
People with ABPA/CPA or bronchiectasis can have more severe or longer-lasting symptoms from flu, RSV, or COVID-19. Practical steps:
-
Get your vaccines when invited.
-
Act early if you become unwell.
-
Keep your baseline care tight.
-
Continue airway clearance, inhalers/other prescribed medicines, and your personalised action plan.
-
Ask about a rescue plan (who to call, when to test, when to increase treatments).
-
-
Reduce exposure where you can.
-
Improve ventilation, avoid poorly ventilated crowded spaces during peaks, consider masking indoors when rates rise, and hand hygiene.
-
Bottom line
-
Many experts anticipate a busier-than-average flu season in the UK/Europe this winter, but outcomes are not fixed. What we each do—vaccination, early help if ill, and sensible precautions—can make a big difference.
Share this post
Latest News posts
The importance of detecting cancer early
July 8, 2022
Fungal Infection Trust
July 5, 2022
Aspergillosis and Fatigue
June 20, 2022
Singing for lung health
May 24, 2022
Monkeypox outbreak
May 23, 2022
Drug Induced Photosensitivity
May 9, 2022
Medical Alert Paraphernalia
February 21, 2022
Advice for patients on long-term steroid treatment
February 21, 2022
Adrenal insufficiency
February 4, 2022
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
